Trial · NCT06361823
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
NCT06361823, Phase 3, Unknown, Capital Medical University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment. Trials, record NCT06361823. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06361823
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
- NCT number
- NCT06361823
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 74 participants, estimated
- Lead sponsor
- Capital Medical University
- Conditions
- Idiopathic Intracranial Hypertension
- Interventions
- Semaglutide, Low calorie diet
- First posted
- 2024-04-12
- Last updated
- 2024-04-12
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intracranial pressure | 12 weeks | The intracranial pressure is represented by the cerebrospinal fluid pressure measured by lumbar puncture in a lateral position. |
| Primary | Adverse reactions | 12 weeks | Adverse reactions include gastrointestinal reactions (such as nausea, vomiting, diarrhea), hypoglycemia, allergic reactions (such as rapid allergic reactions, vascular edema). |
| Secondary | Headache severity | Baseline + 12 weeks | It is measured by the questionnaire "Headache Impact Test-6" (HIT-6); score range is 36-78. The higher the score, the more severe the headache. |
| Secondary | Degree of papilledema | Baseline + 12 weeks | It is represented by the Frisén Grade (0-5, 0 is the minimal, 5 is the worst) measured by fundoscope. |
| Secondary | Perimetric mean deviation | Baseline + 12 weeks | It is measured by Humphrey automated perimetry. |
| Secondary | Optic nerve sheath diameter | Baseline + 12 weeks | It is measured by optic nerve sheath ultrasound. |
| Secondary | Body mass index | Baseline + 12 weeks | Change in body mass index. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06361823
GET https://conductscience.org/api/trials/v1/NCT06361823/registered